Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

Clinical trial NCT00964106 · COMPLETED

Trial details

NCT number: NCT00964106
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interactions

Start date: 2009-08-26
Primary completion: 2011-08-29
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.